Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 101 results.
User Information
Export Records
  1. 1.   Antisense transcription from lentiviral gene targeting linked to an integrated stress response in colorectal cancer cells
  2. Ha, Taekyu; DiPrima, Michael; Koparde,Vishal; Jailwala,Parthav; Ohnuki, Hidetaka; Feng, Jing-Xin; Palangat, Murali; Larson, Daniel; Tosato, Giovanna
  3. Molecular Therapy. Nucleic Acids. 2022, Jun 14; 28: 877-891.
  1. 3.   Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis
  2. Bode, C.; Kinjo, T.; Alvord, W. G.; Klinman, D. M.
  3. Carcinogenesis. 2014, May; 35(5): 1078-83.
  1. 4.   Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
  2. Shirota, Y.; Shirota, H.; Klinman, D. M.
  3. Journal of Immunology. 2012, Feb; 188(4): 1592-1599.
  1. 5.   A Direct, Efficient Method for the Preparation of siRNAs Containing Ribo-like North Bicyclo[3.1.0]hexane Pseudosugars
  2. Terrazas, M.; Avino, A.; Siddiqui, M. A.; Marquez, V. E.; Eritja, R.
  3. Organic Letters. 2011, Jun; 13(11): 2888-2891.
  1. 6.   Inhibition of multi-drug resistant HIV-1 reverse transcriptase by nucleoside beta-triphosphates
  2. Dash, C.; Ahmadibeni, Y.; Hanley, M. J.; Pandhare, J.; Gotte, M.; Le Grice, S. F. J.; Parang, K.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Jun; 21(12): 3519-3522.
  1. 7.   The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides
  2. Yamamoto, M.; Sato, T.; Beren, J.; Verthelyi, D.; Klinman, D. M.
  3. Biomaterials. 2011, Jun; 32(18): 4238-4242.
  1. 8.   CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity
  2. Shirota, H.; Klinman, D. M.
  3. Cancer Immunology Immunotherapy. 2011, May; 60(5): 659-669.
  1. 9.   Probing Cellular Processes with Oligo-Mediated Recombination and Using the Knowledge Gained to Optimize Recombineering
  2. Sawitzke, J. A.; Costantino, N.; Li, X. T.; Thomason, L. C.; Bubunenko, M.; Court, C.; Court, D. L.
  3. Journal of Molecular Biology. 2011, Mar; 407(1): 45-59.
  1. 10.   Understanding the effects of carbocyclic sugars constrained to north and south conformations on RNA nanodesign
  2. Kim, T.; Barchi, J. J.; Marquez, V. E.; Shapiro, B. A.
  3. Journal of Molecular Graphics & Modelling. 2011, Feb; 29(5): 624-634.
  1. 11.   Structural modifications of nucleosides in ionic liquids
  2. Kumar, V.; Parmar, V. S.; Malhotra, S. V.
  3. Biochimie. 2010, Sep; 92(9): 1260-1265.
  1. 12.   Short- and long-term changes in gene expression mediated by the activation of TLR9
  2. Klaschik, S.; Tross, D.; Shirota, H.; Klinman, D. M.
  3. Molecular Immunology. 2010, Mar; 47(6): 1317-1324.
  1. 13.   Synthesis of nucleoside 5 '-O-alpha,beta-methylene-beta-triphosphates and evaluation of their potency towards inhibition of HIV-1 reverse transcriptase
  2. Ahmadibeni, Y.; Dash, C.; Hanley, M. J.; Le Grice, S. F. J.; Agarwal, H. K.; Parang, K.
  3. Organic & Biomolecular Chemistry. 2010, Mar; 8(6): 1271-1274.
  1. 14.   Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants
  2. Klinman, D. M.; Klaschik, S.; Tomaru, K.; Shirota, H.; Tross, D.; Ikeuchi, H.
  3. Vaccine. 2010, Feb; 28(8): 1919-1923.
  1. 15.   Quantitative Analysis of MAP-Mediated Regulation of Microtubule Dynamic Instability In Vitro-Focus on Tau
  2. Kiris, E.; Ventimiglia, D.; Feinstein, S. C.
  3. Methods in cell biology. 2010; 95 : 481-503.
  1. 16.   Oligonucleotide recombination in Gram-negative bacteria
  2. Swingle, B.; Markel, E.; Costantino, N.; Bubunenko, M. G.; Cartinhour, S.; Court, D. L.
  3. Molecular Microbiology. 2010, Jan; 75(1): 138-148.
  1. 17.   Accelerated wound healing mediated by activation of Toll-like receptor 9
  2. Sato, T.; Yamamoto, M.; Shimosato, T.; Klinman, D. M.
  3. Wound Repair and Regeneration. 2010, Nov-Dec; 18(6): 586-593.
  1. 18.   Synthesis and Hybridization Properties of Modified Oligodeoxynucleotides Carrying Non-Natural Bases
  2. Avino, A.; Perez-Rentero, S.; Garibotti, A. V.; Siddiqui, M. A.; Marquez, V. E.; Eritja, R.
  3. Chemistry & Biodiversity. 2009 6(2): 117-126.
  1. 19.   Methods for the analysis of HIV-1 nucleocapsid protein interactions with oligonucleotides
  2. Stephen, A. G.; Fisher, R. J.
  3. Methods in molecular biology (Clifton, N.J.). 2009 485: 209-221.
  1. 20.   Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3
  2. Tross, D.; Petrenko, L.; Klaschik, S.; Zhu, Q.; Klinman, D. M.
  3. Molecular Immunology. 2009 46(13): 2557-2564.
  1. 21.   Tonsillar Application of AT-2 SIV Affords Partial Protection Against Rectal Challenge With SIVmac239
  2. Vagenas, P.; Williams, V. G.; Piatak, M.; Bess, J. W.; Lifson, J. D.; Blanchard, J. L.; Gettie, A.; Robbiani, M.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2009 52(4): 433-442.
  1. 22.   Effect of CpG oligonucleotides on vaccine-induced B cell memory
  2. Tross, D.; Klinman, D. M.
  3. Journal of Immunology. 2008 181(8): 5785-5790.
  1. 23.   Multicopy plasmid modification with phage lambda red recombineering
  2. Thomason, L. C.; Costantino, N.; Shaw, D. V.; Court, D. L.
  3. Plasmid. 2007, Sep; 58(2): 148-158.
  1. 24.   The history of N-methanocarbathymidine: The investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent
  2. Marquez, V. E.; Hughes, S. H.; Sei, S.; Agbaria, R.
  3. Antiviral Research. 2006, Sep; 71(2-3): 268-275.
  1. 25.   A set of recombineering plasmids for gram-negative bacteria
  2. Datta, S.; Costantino, N.; Court, D. L.
  3. Gene. 2006, Sep; 379: 109-115.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel